• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, SA SYS-MYLA; SYS-MYLA®

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, SA SYS-MYLA; SYS-MYLA® Back to Search Results
Catalog Number 4700384
Device Problem Computer Software Problem (1112)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer in (b)(6) notified biomérieux of a data integration issue when using the myla® system (ref.4700384, serial (b)(4)) in conjunction with their virtuo® instrument.The customer confirmed the patient bottle incubation time was adjusted from five (5) days to fourteen (14) days at the lis (laboratory information system).However, the impacted bottle was expelled from the virtuo after five (5) days of incubation and showed a result of negative.The customer noticed the bottle should not have been expelled and reloaded it on the virtuo and completed its incubation.There is no indication or report from the laboratory that the premature bottle expulsion led to any adverse event related to the patient's state of health.Biomérieux will initiate an internal investigation.
 
Manufacturer Narrative
Biomérieux conducted an internal investigation in response to a customer complaint of data integration issue when using the myla® system (ref.4700384, serial (b)(6)) in conjunction with their virtuo® instrument.A patient bact/alert® bottle was automatically unloaded from the virtuo® instrument after five (5) days of incubation instead of the set fourteen (14) days.Biomérieux reviewed the customer¿s lis logs.This review found that two (2) messages with the same information were sent at the same time.It was also confirmed the that was not present in the maximum test time (mtt).Biomérieux confirmed if is not present when updating the mtt, the test time will remain five (5) days of incubation.These details on adjusting the mtt are present in the service manual - 161150-1283 - a - en - connectivity bci - myla 4.X ¿ lis.The investigation concluded the instructions in the service manual for adjusting the maximum test time were not followed and that the myla® system is performing as intended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYS-MYLA
Type of Device
SYS-MYLA®
Manufacturer (Section D)
BIOMERIEUX, SA
3 route de port michaud
la balme 38390
FR  38390
MDR Report Key9877612
MDR Text Key224739190
Report Number9615754-2020-00046
Device Sequence Number1
Product Code JQP
UDI-Device Identifier03573026369767
UDI-Public03573026369767
Combination Product (y/n)N
PMA/PMN Number
C 1 EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 07/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number4700384
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/18/2020
Initial Date FDA Received03/25/2020
Supplement Dates Manufacturer Received06/09/2020
Supplement Dates FDA Received07/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-